VCI Wealth Management LLC raised its holdings in Colgate-Palmolive (NYSE:CL – Free Report) by 46.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 17,547 shares of the company’s stock after purchasing an additional 5,599 shares during the quarter. VCI Wealth Management LLC’s holdings in Colgate-Palmolive were worth $1,595,000 as of its most recent SEC filing.
A number of other large investors have also recently modified their holdings of CL. Union Bancaire Privee UBP SA acquired a new stake in shares of Colgate-Palmolive during the 4th quarter valued at $32,000. Reston Wealth Management LLC acquired a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at $42,000. Capital Performance Advisors LLP acquired a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at $53,000. Prospera Private Wealth LLC acquired a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at $64,000. Finally, True Wealth Design LLC boosted its holdings in shares of Colgate-Palmolive by 1,460.9% during the 3rd quarter. True Wealth Design LLC now owns 718 shares of the company’s stock valued at $75,000 after acquiring an additional 672 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.
Insider Buying and Selling at Colgate-Palmolive
In other news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. The trade was a 55.29 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.34% of the company’s stock.
Analyst Ratings Changes
Check Out Our Latest Stock Analysis on Colgate-Palmolive
Colgate-Palmolive Price Performance
CL stock opened at $91.19 on Tuesday. The company has a market capitalization of $74.50 billion, a P/E ratio of 26.13, a price-to-earnings-growth ratio of 3.59 and a beta of 0.44. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. Colgate-Palmolive has a 52-week low of $82.68 and a 52-week high of $109.30. The business has a 50-day simple moving average of $91.81 and a two-hundred day simple moving average of $97.45.
Colgate-Palmolive Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.19%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 57.31%.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Stories
- Five stocks we like better than Colgate-Palmolive
- How to Find Undervalued Stocks
- 3 Consumer Stocks Call Option Traders Are Betting Big On
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Duolingo: An Unexpected Benefactor From the TikTok Ban
- Top Biotech Stocks: Exploring Innovation Opportunities
- Trump Index: 6 Companies Linked to Trump’s Cabinet Worth Watching
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.